BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 7037618)

  • 21. Neonatal thymus grafts. I. Studies on the regulation of the level of circulating thymic factor (FTS).
    Tubiana N; Dardenne M
    Immunology; 1979 Feb; 36(2):207-13. PubMed ID: 437830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An analysis of the defective response of CBA/N mice to T-dependent antigens.
    Janeway CA; Barthold DR
    J Immunol; 1975 Oct; 115(4):898-900. PubMed ID: 1080771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells.
    Savino W; Dardenne M; Bach JF
    Clin Exp Immunol; 1983 Apr; 52(1):7-12. PubMed ID: 6683135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The stromal cell line S17 supports the growth of lipopolysaccharide-stimulated CBA/N spleen cell colonies in vitro.
    Narendran A; Cumano A; Dorshkind K; Paige CJ
    Eur J Immunol; 1992 Apr; 22(4):1001-6. PubMed ID: 1551400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of the polyclonal B-cell response to lipopolysaccharide by concanavalin-A-treated non-T cells in vitro.
    Matsumoto T; Nakano M; Shibata M
    Immunology; 1982 Dec; 47(4):651-61. PubMed ID: 6216201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential endotoxin sensitivity of lymphocytes and macrophages from mice with an X-linked defect in B cell maturation.
    Rosenstreich DL; Vogel SN; Jacques A; Wahl LM; Scher I; Mergenhagen SE
    J Immunol; 1978 Aug; 121(2):685-90. PubMed ID: 308077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B cell maturation factor: effects on various cell populations.
    Sidman CL; Marshall JD
    J Immunol; 1984 Feb; 132(2):845-50. PubMed ID: 6418813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell regulation of polyclonal B cell responsiveness. I. Helper effects of T cells.
    Goodman MG; Weigle WO
    J Immunol; 1979 Jun; 122(6):2548-53. PubMed ID: 376737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do epidermal cells produce thymic hormones in vivo? An immunohistochemical study using anti-thymic hormone antibodies.
    Nicolas JF; Auger C; Dardenne M; Thivolet J
    Thymus; 1988-1989; 12(3):187-201. PubMed ID: 3075100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune responses to xanthan gum. I. The characteristics of lymphocyte activation by xanthan gum.
    Ishizaka S; Sugawara I; Hasuma T; Morisawa S; Möller G
    Eur J Immunol; 1983 Mar; 13(3):225-31. PubMed ID: 6832212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of facteur thymique sérique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells.
    Monier JC; Dardenne M; Pléau JM; Schmitt D; Deschaux P; Bach JF
    Clin Exp Immunol; 1980 Dec; 42(3):470-6. PubMed ID: 7011612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of a nonapeptide thymic hormone on intestinal intraepithelial lymphocytes in mice following administration of 5-fluorouracil.
    Inagaki-Ohara K; Kobayashi N; Nishimura H; Sakai T; Matsumoto Y; Hiromatsu K; Awaya A; Yoshikai Y
    Cell Immunol; 1996 Jul; 171(1):30-40. PubMed ID: 8660834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice with the xid mutation lack the regulatory antibodies that are necessary for the induction of contrasuppression.
    Simpson SD; Ernst PB
    Cell Immunol; 1995 Aug; 164(1):126-32. PubMed ID: 7634344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of low-dose paralysis in the absence of the ability to secrete antibody.
    Markham RB; Stashak PW; Prescott B; Amsbaugh DF; Baker PJ
    J Immunol; 1978 Mar; 120(3):986-90. PubMed ID: 24665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological defects in SJL mice.
    Hutchings PR; Varey AM; Cooke A
    Immunology; 1986 Nov; 59(3):445-50. PubMed ID: 2947846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymic atrophy in type 2 reovirus infected mice: immunosuppression and effects of thymic hormone. Thymic atrophy caused by reo-2.
    Onodera T; Taniguchi T; Tsuda T; Yoshihara K; Shimizu S; Sato M; Awaya A; Hayashi T
    Thymus; 1991 Sep; 18(2):95-109. PubMed ID: 1656552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental malaria in the CBA/N mouse.
    Jayawardena AN; Janeway CA; Kemp JD
    J Immunol; 1979 Dec; 123(6):2532-9. PubMed ID: 387872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective removal of T cell function from mouse lymphocyte suspensions by treatment with normal guinea pig serum.
    Kierszenbaum F; Budzko DB; Miller HC
    J Immunol; 1980 Apr; 124(4):1599-602. PubMed ID: 6988503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of T15 idiotype dominance. I. Mice expressing the xid immune defect provide normal help to T15+ B cell precursors.
    Kenny JJ; Wicker LS; Guelde G; Scher I
    J Immunol; 1982 Oct; 129(4):1534-8. PubMed ID: 6980941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum thymic factor (FTS) restores the ability of adult thymectomized mice to be suppressed by hapten-modified self.
    Grouix B; Charreire J; Erard D; Galanaud P; Bach JF
    Cell Immunol; 1981 Oct; 64(1):144-9. PubMed ID: 6457694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.